Joint RCOG BMS statement: Lancet study examines use of HRT and ovarian cancer risk A study published today (13 February) in The Lancet looks at short-term use of hormone replacement therapy (HRT) and the possible increa - The Million Women Study - Document - PDFSEARCH.IO

First Page	Meta Content
	Joint RCOG/BMS statement: Lancet study examines use of HRT and ovarian cancer risk A study published today (13 February) in The Lancet looks at short-term use of hormone replacement therapy (HRT) and the possible increa Add to Reading List Document Date: 2015-02-16 13:39:00 Open Document File Size: 87,52 KB Share Result on Facebook Continent North America / Europe / / Country Australia / / MedicalCondition ovarian cancer / serious disease / / MedicalTreatment HRT / hormone replacement therapy / / Organization British Menopause Society / / Person Clare McKenzie / Heather Currie / / Position Chairman / spokesperson / Vice President / / SocialTag Menstrual cycle Hormone replacement therapy Ovarian cancer The Million Women Study Oophorectomy Medicine Menopause Gender transitioning

Joint RCOG/BMS statement: Lancet study examines use of HRT and ovarian cancer risk A study published today (13 February) in The Lancet looks at short-term use of hormone replacement therapy (HRT) and the possible increaAdd to Reading List